Electronic Cigarette Use
54
8
8
41
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
11 trials with published results (20%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.9%
1 terminated out of 54 trials
97.6%
+11.0% vs benchmark
4%
2 trials in Phase 3/4
27%
11 of 41 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 41 completed trials
Clinical Trials (54)
Methadone-Maintained Smokers Switching to E-Cigarettes
Assessing the Effect of Nicotine Reduction on ENDS User's Addiction and Exposures
Just-in-Time Support for Smoking, Vaping, and Eating Urges During High-Stress Moments Among Gender and Sexual Minority Adults in Dhaka
Developing and Testing Health Warning Labels on the ENDS Device
Effect of E-Liquid Flavor on Respiratory Symptoms in People Using Electronic Nicotine Delivery Systems
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
Nicotine and Cannabis Vape Labeling Experiment - Spring 2025
Cessation of Smoking Trial in the Emergency Department
Development of UP2UTobacco for High School Youth
The Avenues Study: Dual Use Cessation
Effect of Cannabis on E-Cigarette Use Behavior
Effect of Menthol on ENDS Users' Addiction and Exposure
Assessing Electronic Cigarette Nicotine Flux
Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening
The Impact of Oral Ethanol and Vaped Ethanol on the Evaluation of Impairment
Effects of E-cigarette Use on Health
Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use
CAN-DOSE Study: Cessation With Augmented Nicotine for Dual Use Of Smoking and E-cigarettes
E-cigarettes for Harm Reduction in Adults With Asthma
Dual Use of ENDS and Combustible Cigarettes